BIOMAT Database Logo BIOMAT Database Logo

Interleukin-2 reconstitutes natural killer activity in transplant recipients. 1989

F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Department of Surgery, Catholic Univeristy of Rome, Italy.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Natural killer cell activity in cardiac transplant recipients.
September 1987, Transplantation,
F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
In vitro interleukin 2 and natural killer activity in renal allograft recipients.
February 1987, Transplantation proceedings,
F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Natural killer cell activity in renal transplant recipients receiving cyclosporine.
September 1983, Infection and immunity,
F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Interleukin-2, interferon-gamma and natural killer cell activity in bronchoalveolar lavage fluid from marrow transplant recipients with cytomegalovirus pneumonia.
February 1993, Bone marrow transplantation,
F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Interleukin-2 augments natural killer cell activity.
May 1981, Nature,
F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Depressed natural killer function in transplant recipients: an analysis.
December 1984, Transplantation proceedings,
F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Natural killer activity in kidney allograft recipients.
September 1981, Transplantation proceedings,
F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Recombinant interleukin 2 rapidly augments human natural killer cell activity.
June 1985, Cellular immunology,
F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Interleukin 2 dependence of human natural killer (NK) cell activity.
April 1983, Journal of immunology (Baltimore, Md. : 1950),
F Citterio, and R Cauda, and U Pozzetto, and M Tumbarello, and F Serino, and L Ortona, and M Castagneto
Interleukin-2 and natural killer activity in acute type B hepatitis.
August 1991, Hepato-gastroenterology,
Copied contents to your clipboard!